Latest Regulatory Scrutiny News

Ionic Rare Earths Limited’s IXRO securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

ASIC has initiated civil proceedings against Fiducian’s subsidiary, alleging misleading statements and compliance failures related to a now-closed investment fund. Fiducian is cooperating but remains tight-lipped as the case unfolds.

European Lithium Limited will lift its trading suspension on 3 October 2025 following the release of its Annual Financial Report, marking a key milestone for investors.

Nelson Resources has confirmed it is in confidential negotiations for a Right to Mine contract, explaining recent unusual trading activity in its shares. The company maintains compliance with ASX disclosure rules while awaiting contract finalisation.

Seven West Media and Southern Cross Media have announced a proposed all-scrip merger to create a leading integrated media company spanning TV, audio, digital, and publishing platforms across Australia.

Australian Clinical Labs has reached a $6.2 million settlement with the Australian Information Commissioner to resolve a Federal Court case stemming from a 2022 cyberattack on its newly acquired Medlab Pathology business.

Computershare Limited has agreed to sell its UK Mortgage Services business to Pepper Advantage, marking a strategic step to streamline operations and enhance earnings quality without altering FY26 profit forecasts.

The NSW Independent Casino Commission has prolonged the suspension of The Star Sydney casino licence and extended the manager’s term, signaling ongoing regulatory scrutiny and remediation efforts.

Emu NL has agreed to delay issuing shortfall securities from its entitlement offer until after its extraordinary general meeting on 29 September 2025, following a regulatory undertaking accepted by the Takeovers Panel.

An application to the Takeovers Panel challenges Duxton Farms’ recent merger and share placement, alleging undisclosed associations and potential breaches of takeover laws by major shareholders.

333D Limited has had its trading suspension lifted following a capital raise announcement and response to an ASX price query, signaling renewed market activity.

Renergen Limited and ASP Isotopes Inc. have proactively extended the deadline to fulfill outstanding conditions for their Scheme of Arrangement offer to 28 November 2025, following key regulatory approvals and ongoing collaboration.